comprehensive -WSS

comprehensive

author：fashion 2025-10-01 23:05:53 - browse：923

There’s a specter haunting Wall Street.

It started in biotech, where companies making drugs for the obesity-related liver disease NASH saw their valuations crash on the assumption that GLP-1 weight loss treatments would cut them out of the market. Then the Ozempic panic came for dialysis firms, whose stocks fell about 20% in a single day on the news that Novo Nordisk’s medicine had delayed the progression of kidney disease in a study enrolling people with type 2 diabetes.

Now analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs’ growing popularity, said Jared Holz, a health care specialist at Mizuho Securities. Buy Bumble, sell McDonald’s. Short Pepsi, go long Louis Vuitton. Put your money in sectors that cater to a svelte and sated brand of consumer, and get out of the ones that rely on excess and compulsion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： RaDonda Vaught to speak at CommonSpirit event on patient safety

hotspot

WSS

Readout LOUD podcast: mifepristone case, GLP

Supreme Court mifepristone arguments center on docs' right to sue

Primary care physicians play key roles in Alzheimer's management

RaDonda Vaught to speak at CommonSpirit event on patient safety

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Eliminate the waiting period for sterilization covered by Medicaid

focus

comprehensive

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

International team creates first chimeric human

As demand for Covid shots wanes, Moderna seeks its next success

Oprah kicked off a national conversation on obesity. Let's have it

Trump demands the U.S. pay no more for drugs than other countries … again

States should stop sabotaging methadone treatment reform

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Steward Health Care has deal to sell doctor network to UnitedHealth

ChatGPT in medicine: STAT answers readers' burning questions

Abortion pill Supreme Court ruling could impact entire drug industry

focus

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Biotech companies concerned about China biosecurity crackdown

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Congress gives doctors Medicare pay bump

Washington mulls new rules to avert another Change Healthcare

hotspot

hotspot

Wikipedia

focus